What is the official website of AbbVie | Virology ?

The official website of AbbVie | Virology is https://www.abbvie.com/our-science/therapeutic-focus-areas/virology.html.

What is AbbVie | Virology's cybersecurity risk score?

AbbVie | Virology has an AI-generated cybersecurity risk score of 754 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has AbbVie | Virology experienced?

According to Rankiteo, AbbVie | Virology currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has AbbVie | Virology been affected by any supply chain cyber incidents ?

According to Rankiteo, AbbVie | Virology has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does AbbVie | Virology have SOC 2 Type 1 certification ?

According to Rankiteo, AbbVie | Virology is not certified under SOC 2 Type 1.

Does AbbVie | Virology have SOC 2 Type 2 certification ?

According to Rankiteo, AbbVie | Virology does not hold a SOC 2 Type 2 certification.

Does AbbVie | Virology comply with GDPR ?

According to Rankiteo, AbbVie | Virology is not listed as GDPR compliant.

Does AbbVie | Virology have PCI DSS certification ?

According to Rankiteo, AbbVie | Virology does not currently maintain PCI DSS compliance.

Does AbbVie | Virology comply with HIPAA ?

According to Rankiteo, AbbVie | Virology is not compliant with HIPAA regulations.

Does AbbVie | Virology have ISO 27001 certification ?

According to Rankiteo,AbbVie | Virology is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does AbbVie | Virology operate in ?

AbbVie | Virology operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does AbbVie | Virology have ?

AbbVie | Virology employs approximately None employees people worldwide.

Does AbbVie | Virology own any subsidiaries ?

AbbVie | Virology presently has no subsidiaries across any sectors.

How many LinkedIn followers does AbbVie | Virology have ?

AbbVie | Virology's official LinkedIn profile has approximately 2,321 followers.

What is the NAICS classification code for AbbVie | Virology ?

AbbVie | Virology is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does AbbVie | Virology have a Crunchbase profile ?

No, AbbVie | Virology does not have a profile on Crunchbase.

Does AbbVie | Virology have a LinkedIn profile ?

Yes, AbbVie | Virology maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/abbvie-virology.

How many cybersecurity incidents has AbbVie | Virology experienced ?

As of August 7, 2026, Rankiteo reports that AbbVie | Virology has experienced 2 cybersecurity incidents.

How many peer or competitor companies does AbbVie | Virology have ?

AbbVie | Virology has an estimated 5,725 peer or competitor companies worldwide.

What types of cybersecurity incidents has AbbVie | Virology faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Vulnerability and Breach.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Boost Score +25 with badge (5 left)

754

/1000

Fair

779

/1000

Fair

AbbVie | Virology Vendor Cyber Rating & Cyber Score

abbvie.com

Add Your Compliance Badge

Follow us here on LinkedIn for global news and updates on the work being done to advance the science and understanding of HIV and AbbVie’s HCV elimination efforts. We believe that we all have our own part to play in making HCV elimination the next public health story, and forming transformative partnerships is essential to helping solve some of the most pressing challenges for the HCV community. Review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html

AV A.I CyberSecurity Scoring

Scoring History

AbbVie | Virology CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

AbbVie

Vulnerability

100

4/2026

EGAABB177565877...

AbbVie | Virology

Breach

100

6/2023

ABB0473723

Loading…

A.I.

AV Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for AV

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for AbbVie | Virology in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for AbbVie | Virology in 2026.

Incident Types AV vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for AbbVie | Virology in 2026.

Incident History - AV (X = Date, Y = Severity)

Loading…

SUBSIDIARY

AbbVie | Virology Subsidiaries

AV

Pharmaceutical Manufacturing

Website: https://www.abbvie.com/our-science/therapeutic-focus-areas/virology.html

Company Size: 10,001+ employees

AbbViePharmaceutical Manufacturing

OncologyPharmaceutical Manufacturing

Allergan AestheticsPharmaceutical Manufacturing

CoolSculptingMedical Equipment Manufacturing

BOTOX® Cosmetic (onabotulinumtoxinA)Pharmaceutical Manufacturing

Allergan Medical InstitutePharmaceutical Manufacturing

Allergan Aesthetics Plastic and Regenerative Medicine PortfolioMedical Equipment Manufacturing

Natrelle Breast ImplantsPharmaceutical Manufacturing

JUVÉDERM® Collection of FillersPharmaceutical Manufacturing

Pharmacyclics, an AbbVie CompanyPharmaceutical Manufacturing

AbbVieEyetoEyePharmaceutical Manufacturing

ImmunologyPharmaceutical Manufacturing

NeurosciencePharmaceutical Manufacturing

Allergan Eye CarePharmaceutical Manufacturing

AbbVieEyetoEyePharmaceutical Manufacturing

Loading…

AbbVie | Virology Similar Companies

Astellas Pharma

astellas.com

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines

Glenmark Pharmaceuticals

glenmarkpharma.com

Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our journey of innovation over the past four and a half decades, we have evolved from a generics company to a global organization offering specialty and branded products. Glenmark’s core values of Achievement, Respect, and Knowledge impart a sense of organizational unity that drives our growth. We have established a robust global branded generics, specialty, and OTC business; with a significant presence in the therapy areas of dermatology, respiratory, and oncology. Our ten state-of-the-art manufacturing facilities spread across four continents with operations in over 80 countries help us impact millions of patients across the globe. We recently consolidated our innovation efforts in small molecules and biologics research with the formation of ‘Ichnos Glenmark Innovation’ (IGI). This alliance is aimed at leveraging the capabilities of Glenmark and its subsidiary, Ichnos Sciences, to accelerate innovation in cancer treatment. To know more about IGI, check out: https://iginnovate.com/ Sustainability is an integral aspect of all our operations and we are focused on achieving our Environment, Social and Governance (ESG) goals. Our responsibility also extends to our communities, and over the years, our CSR efforts have touched the lives of over 3 million people.

Viatris

viatris.com

Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale. In 2022 alone, we supplied high-quality medicines to approximately 1 billion patients around the world. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world’s most enduring health challenges, access takes on deep meaning at Viatris. We have the ability to touch all of life’s moments, from birth to end of life, acute conditions to chronic diseases. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India Social Media Guidelines: https://newsroom.viatris.com/social-media-community-guidelines Investors: https://investor.viatris.com Corporate Social Responsibility: https://www.viatris.com/sustainability Connect with Viatris Instagram: https://www.instagram.com/viatrisinc X: https://www.x.com/viatrisinc Viatris and our recruiting firms will not ask for sensitive personal information, such as your social security number, date of birth or bank account details via text, email or social media. Additionally, Viatris representatives do not request payment or personal bank information nor send payment to purchase hardware on your own. Viatris.com is the primary source of all company job postings and authorized third-party career websites.

Sanofi

sanofi.com

We are an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms

Sandoz

sandoz.com

Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health challenges such as antimicrobial resistance. We are present in more than 100 countries and our medicines serve some 500 million people every year. We have two main global businesses: Generics - divided between standard generics and complex generics - and Biosimilars. Read our community engagement guidelines: http://bit.ly/4ofoggc

Hikma Pharmaceuticals

cb hikma.com

For almost 50 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 800* high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians and pharmacists need to treat their patients across North America, MENA and Europe. We have 29 manufacturing plants, 3 R&D hubs and c9,500 employees worldwide. *As of December 2025 Subscribe to our channel on YouTube https://youtube.com/@hikmapharmaceuticals5668 For all product information and enquiries, please contact us at [email protected]

Dr. Reddy's Laboratories

drreddys.com

Established in 1984, we are a global pharmaceutical company headquartered in Hyderabad, India. Driven by our purpose of ‘Good Health Can’t Wait’, we work to provide access to affordable and innovative medicines. We offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major markets include USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in future growth drivers such as access to novel molecules, digital therapeutics and consumer healthcare. As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance. For more information, log on to: www.drreddys.com. Caution Notice: Dr. Reddy's has been made aware of candidates receiving fraudulent job opportunities from unauthorised recruiting agencies or people impersonating Dr. Reddy's leaders. These fraudulent jobs may be advertised on employment sites or mimic our careers site and company email addresses. Please know that Dr. Reddy's Laboratories has no affiliation or connection to these situations. Dr. Reddy's (and its associated/group companies) follows a formal recruitment process through its own HR department. Please report immediately in case you suspect a fraudulent job. You may raise your concern by: Accessing https://drreddys.ethicspoint.com. Calling on the hotline number. List of hotline numbers are available in https://drreddys.ethicspoint.com. The hotline is available 24x7 in multiple languages. Writing to [email protected] or [email protected]. For our community guidelines on LinkedIn, please visit: https://shorturl.at/LTvNZ

Eli Lilly and Company

lilly.com

We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges. General Information and Guidelines: When you engage with us on LinkedIn, you're agreeing to these Community Guidelines: https://e.lilly/guidelines. If you have questions about a Lilly medicine, contact The Lilly Answers Center at 1-800-Lilly-Rx (1-800-545-5979) Monday through Friday, excluding company holidays.

AUROBINDO PHARMA LTD

aurobindo.com

Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, branded specialty drugs, and active pharmaceutical ingredients (APIs) across more than 150 countries. It is ranked among the top 10 generic companies in eight European nations and holds the distinction of being the largest generic pharmaceutical company in the United States. With over 30 state-of-the-art manufacturing and packaging facilities approved by leading global regulatory authorities including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, and Brazil ANVISA, Aurobindo Pharma ensures the highest standards of quality. Its robust portfolio spans eight major therapeutic areas: Central Nervous System (CNS), Antiretroviral (ARV), Cardiovascular (CVS), Antibiotics, Gastroenterology, Anti-diabetics, Oncology, and Dermatology, supported by a strong R&D infrastructure that drives innovation, affordability, and accessibility.

Loading…

NEWS

AbbVie | Virology CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

March 08, 2026 08:00 AM

Hackers Allegedly Selling Exploit for Windows Remote Desktop Services 0-Day Flaw

A critical zero-day elevation of privilege vulnerability in Windows Remote Desktop Services (RDS), tracked as CVE-2026-21533, is reportedly...

Read Article

February 20, 2026 08:00 AM

AbbVie Inc. SEC 10-K Report

AbbVie Inc., a global biopharmaceutical company specializing in the research, development, manufacturing, and commercialization of...

Read Article

February 04, 2026 08:00 AM

Cybersecurity & Privacy Group Of The Year: Covington

Covington & Burling LLP helped Papa John's and Bloomingdale's win circuit court appeals in privacy class actions, helped Delta Air Lines...

Read Article

August 22, 2025 02:51 PM

Rachel James, AbbVie: Harnessing AI for corporate cybersecurity

Close-up of a laptop as AI News caught up with Rachel James, Principal. Share this story:.

Read Article

August 11, 2025 07:00 AM

Cencora & The Lash Group Settle Data Breach Litigation for $40 Million

Cencora, The Lash Group, and their affiliates have agreed to pay $40 million to settle class action data breach litigation over a February...

Read Article

July 28, 2025 07:00 AM

Overcoming diagnostic and data privacy challenges in viral disease detection: an integrated approach using generative AI, vision transformers, explainable AI, and federated learning

The growing dependence on artificial intelligence (AI) in healthcare has significantly advanced the detection and diagnosis of viral...

Read Article

March 19, 2025 07:00 AM

Progress from our Frontier Red Team

In this post, we are sharing what we have learned about the trajectory of potential national security risks from frontier AI models.

Read Article

February 28, 2025 05:37 AM

abbv-20241231

AbbVie is a global, diversified research-based biopharmaceutical company positioned for success with a comprehensive product portfolio.

Read Article

December 24, 2024 08:00 AM

Action likely against AbbVie executive who signed self-declaration

Pharma cos and docs say medical conferences have declined since March after UCPMP was notified.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-8325

SUMMARY

A maliciously crafted PDF file, when parsed through Autodesk Revit, can force an Out-of-Bounds Write vulnerability. A malicious actor may leverage this vulnerability to cause a crash, cause data corruption, or execute arbitrary code in the context of the current process.

Published

Date2026-08-06

Updated

Date2026-08-06

RISK INFORMATION (Score: 7.8)

cvss3

Base Score: 7.8

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

1.8

REFERENCES

CVE-2026-7867

SUMMARY

A flaw was found in udisks2. A local attacker with an active console session can exploit insufficient authorization checking on the 'as-user' option in the org.freedesktop.UDisks2.Filesystem.Mount() D-Bus method. This allows the attacker to spoof the 'as-user' parameter, mounting filesystems on behalf of arbitrary users, including privileged accounts. This can lead to local privilege escalation through mount point injection and manipulation of the mount namespace visible to privileged users.

Published

Date2026-08-06

Updated

Date2026-08-06

RISK INFORMATION (Score: 7.8)

cvss3

Base Score: 7.8

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

1.8

REFERENCES

CVE-2026-7406

SUMMARY

A maliciously crafted BMP file, when parsed through certain Autodesk products, can force a Untrusted Pointer Dereference vulnerability. A malicious actor can leverage this vulnerability to execute arbitrary code in the context of the current process.

Published

Date2026-08-06

Updated

Date2026-08-06

RISK INFORMATION (Score: 7.8)

cvss3

Base Score: 7.8

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

1.8

REFERENCES

CVE-2026-7405

SUMMARY

A maliciously crafted TIF file, when parsed through certain Autodesk products during image import, can cause an Out-of-Bounds Read in the image handling library. A malicious actor can leverage this vulnerability to cause a denial of service

Published

Date2026-08-06

Updated

Date2026-08-06

RISK INFORMATION (Score: 5.5)

cvss3

Base Score: 5.5

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:N/I:N/A:H

Impact Score

3.6

Exploitability

1.8

REFERENCES

CVE-2026-71555

SUMMARY

PILOS (Platform for Interactive Live-Online Seminars) is a frontend for BigBlueButton. From 2.1.0 until 4.14.1, PILOS does not send a Cross-Origin-Opener-Policy response header, so pages opened by PILOS via a link that opens a new browsing context (e.g., target="_blank") retain a window.opener reference back to the originating PILOS tab. A malicious destination page reached this way can use window.opener to navigate or manipulate the original PILOS tab, a technique known as reverse tabnabbing, potentially redirecting an authenticated user to a phishing page that mimics PILOS. This issue is fixed in version 4.14.1.

Published

Date2026-08-06

Updated

Date2026-08-06

RISK INFORMATION (Score: 4.1)

cvss3

Base Score: 4.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:N/I:L/A:N

Impact Score

1.4

Exploitability

2.3

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…